RxDoctor Payments Data

Avegiyel Dunn, DO

Family Medicine · Portland, TXNPI 1417224338

Payments from drug & device makers

$2,749in general payments, 2019–2025

Across 198 payments — averaging $13.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$659
  • Pfizer$233
  • Lilly USA, LLC$230
  • Novo Nordisk$217
  • Johnson & Johnson$203
  • GSK$147
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$2,73199%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,749 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$5,343
Medicare patients
38
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin146$248,644
Bydureon BciseExenatide Microspheres63$149,396
OzempicSemaglutide95$107,361
MounjaroTirzepatide86$100,293
TrulicityDulaglutide46$92,657
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog49$88,903
EliquisApixaban72$82,096
FarxigaDapagliflozin Propanediol76$62,878
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog46$52,738
MyrbetriqMirabegron40$46,643
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$29,359
JanuviaSitagliptin Phosphate18$26,872
LinzessLinaclotide24$19,195
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$14,902
SymbicortBudesonide/Formoterol Fumarate45$13,966

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat$130$273,033180 claims
Lilly USA, LLCMounjaro, Trulicity$230$192,950132 claims
Novo NordiskOzempic$217$107,36195 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$659$91,746136 claims
PfizerEliquis$233$82,09672 claims
Astellas Pharma US IncMyrbetriq$23$46,64340 claims
GSKTrelegy Ellipta$147$29,35919 claims
MerckJanuvia$135$26,87218 claims
AbbVieLinzess, Synthroid$113$20,86842 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Portland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →